These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
230 related articles for article (PubMed ID: 2691139)
1. Postischemic mechanical and vascular dysfunction (myocardial "stunning" and microvascular "stunning") and the effects of calcium-channel blockers on ischemia/reperfusion injury. Bolli R; Triana F; Jeroudi MO Clin Cardiol; 1989 Jul; 12(7 Suppl 3):III16-25. PubMed ID: 2691139 [TBL] [Abstract][Full Text] [Related]
2. Calcium antagonists in myocardial ischemia/reperfusion--update 2012. Kleinbongard P; Baars T; Heusch G Wien Med Wochenschr; 2012 Jul; 162(13-14):302-10. PubMed ID: 22695811 [TBL] [Abstract][Full Text] [Related]
3. Ranolazine, an inhibitor of the late sodium channel current, reduces postischemic myocardial dysfunction in the rabbit. Hale SL; Kloner RA J Cardiovasc Pharmacol Ther; 2006 Dec; 11(4):249-55. PubMed ID: 17220471 [TBL] [Abstract][Full Text] [Related]
4. Characterization of "hibernating" and "stunned" myocardium with focus on the use of calcium antagonists in "stunned" myocardium. Ehring T; Schulz R; Heusch G J Cardiovasc Pharmacol; 1992; 20 Suppl 5():S25-33. PubMed ID: 1282610 [TBL] [Abstract][Full Text] [Related]
5. Stunned and hibernating myocardium: possibility of intervention. Ferrari R; La Canna G; Giubbini R; Visioli O J Cardiovasc Pharmacol; 1992; 20 Suppl 5():S5-13. PubMed ID: 1282614 [TBL] [Abstract][Full Text] [Related]
7. Postischemic stunning: the two-phase model for the role of calcium as pathogen. Opie LH; du Toit EF J Cardiovasc Pharmacol; 1992; 20 Suppl 5():S1-4. PubMed ID: 1282606 [TBL] [Abstract][Full Text] [Related]
8. Effects of 3'-angeloyloxy-4'-acetoxy-3',4'-dihydroseselin on myocardial dysfunction after a brief ischemia in anesthetized dogs. Chang TH; Adachi H; Okuyama T; Zhang KY Zhongguo Yao Li Xue Bao; 1994 Sep; 15(5):388-91. PubMed ID: 7717058 [TBL] [Abstract][Full Text] [Related]
9. [Myocardial protection: a look to the future]. Agati L; Penco M; Dagianti A Cardiologia; 1993 Dec; 38(12 Suppl 1):101-9. PubMed ID: 7912649 [TBL] [Abstract][Full Text] [Related]
16. Diastolic Ca2+ overload caused by Na+/Ca2+ exchanger during the first minutes of reperfusion results in continued myocardial stunning. Wei GZ; Zhou JJ; Wang B; Wu F; Bi H; Wang YM; Yi DH; Yu SQ; Pei JM Eur J Pharmacol; 2007 Oct; 572(1):1-11. PubMed ID: 17822695 [TBL] [Abstract][Full Text] [Related]
17. Dynamic progression of contractile and endothelial dysfunction and infarct extension in the late phase of reperfusion. Zhao ZQ; Nakamura M; Wang NP; Velez DA; Hewan-Lowe KO; Guyton RA; Vinten-Johansen J J Surg Res; 2000 Dec; 94(2):133-44. PubMed ID: 11104653 [TBL] [Abstract][Full Text] [Related]
18. Myocardial ischemia/reperfusion-injury, a clinical view on a complex pathophysiological process. Moens AL; Claeys MJ; Timmermans JP; Vrints CJ Int J Cardiol; 2005 Apr; 100(2):179-90. PubMed ID: 15823623 [TBL] [Abstract][Full Text] [Related]
19. Levosimendan: effects of a calcium sensitizer on function and arrhythmias and cyclic nucleotide levels during ischemia/reperfusion in the Langendorff-perfused guinea pig heart. Du Toit EF; Muller CA; McCarthy J; Opie LH J Pharmacol Exp Ther; 1999 Aug; 290(2):505-14. PubMed ID: 10411556 [TBL] [Abstract][Full Text] [Related]
20. Attenuation of regional myocardial stunning by felodipine. Rose J; Heusch G Cardiovasc Drugs Ther; 1996 Jul; 10(3):347-9. PubMed ID: 8877078 [No Abstract] [Full Text] [Related] [Next] [New Search]